# Trial of IV NTG for CD After Second Stage Arrest for the Prevention of Uterine Extension

> **NCT02265965** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 18 (actual)

## Conditions studied

- Prolonged Second Stage of Labor

## Interventions

- **DRUG:** intravenous nitroglycerin

## Key facts

- **NCT ID:** NCT02265965
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2018-07-01
- **Final completion:** 2018-07-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02265965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02265965, "Trial of IV NTG for CD After Second Stage Arrest for the Prevention of Uterine Extension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02265965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*